Literature DB >> 15847807

Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker.

C Ibisch1, G Pradal, J M Bach, B Lieubeau.   

Abstract

For physiological and practical reasons the dog is a large animal model used increasingly to study the pathogenesis of human diseases and new therapeutic approaches, in particular for immune disorders. However, some immunological resources are lacking in this model, especially concerning dendritic cells. The aim of our study was to develop an efficient method to generate dendritic cells (DC) in vitro from dog peripheral blood mononuclear cells (PBMC) and to characterize their functional, structural and ultrastructural properties. PBMC were cultured in vitro with IL-4 and GM-CSF. After 1 week of culture, a great proportion of non-adherent cells displayed typical cytoplasmic processes, as evidenced both by optical and electron microscopy. Cytometric analysis revealed the presence of 41.7+/-24.6% CD14+ cells expressing both CD11c and MHC class II molecules. Allogeneic mixed lymphocyte reactions confirmed the ability of these cultures to stimulate the proliferation of allogeneic lymphocytes as already reported as a characteristic of DC in other species. In addition, we describe for the first time the presence in canine DC of cytoplasmic periodic microstructures (PMS) that could represent ultrastructural markers of canine DC. In conclusion, our study provides an easy method to generate DC from PBMC in sufficient numbers for immunological in vitro investigations in dogs, a pre-clinical model for many human diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15847807     DOI: 10.1016/j.jim.2005.02.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Generation and infection of bovine PBMC-derived dendritic cells with Neospora caninum.

Authors:  G Grandi; C Genchi; C Bazzocchi; M Mortarino; P Borghetti; E De Angelis; L H Kramer
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

2.  Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways.

Authors:  William H Wheat; Lyndah Chow; Jade N Kurihara; Daniel P Regan; Jonathan W Coy; Tracy L Webb; Steven W Dow
Journal:  Stem Cells Dev       Date:  2016-12-22       Impact factor: 3.272

3.  Identification and characterization of canine dendritic cells generated in vivo.

Authors:  Marco Mielcarek; Kristin A Kucera; Richard Nash; Beverly Torok-Storb; Hilary J McKenna
Journal:  Biol Blood Marrow Transplant       Date:  2007-09-07       Impact factor: 5.742

4.  Comparative analysis of canine monocyte- and bone-marrow-derived dendritic cells.

Authors:  Meret Elisabeth Ricklin Gutzwiller; Hervé Raphaël Moulin; Andreas Zurbriggen; Petra Roosje; Artur Summerfield
Journal:  Vet Res       Date:  2010-02-22       Impact factor: 3.683

5.  Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.

Authors:  Weidong Xiong; Marianela Candolfi; Chunyan Liu; A K M Ghulam Muhammad; Kader Yagiz; Mariana Puntel; Peter F Moore; Julie Avalos; John D Young; Dorothy Khan; Randy Donelson; G Elizabeth Pluhar; John R Ohlfest; Kolja Wawrowsky; Pedro R Lowenstein; Maria G Castro
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

6.  Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation.

Authors:  Yu-Shan Wang; Kwan-Hwa Chi; Kuang-Wen Liao; Cheng-Chi Liu; Chiao-Lei Cheng; Yi-Chun Lin; Chiung-Hsiang Cheng; Rea-Min Chu
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

7.  Canine distemper virus infection leads to an inhibitory phenotype of monocyte-derived dendritic cells in vitro with reduced expression of co-stimulatory molecules and increased interleukin-10 transcription.

Authors:  Visar Qeska; Yvonne Barthel; Vanessa Herder; Veronika M Stein; Andrea Tipold; Carola Urhausen; Anne-Rose Günzel-Apel; Karl Rohn; Wolfgang Baumgärtner; Andreas Beineke
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

8.  Evaluation of the Efficacy of the Brucella canis RM6/66 ΔvjbR Vaccine Candidate for Protection against B. canis Infection in Mice.

Authors:  Daniel G Garcia-Gonzalez; Omar H Khalaf; Lauren W Stranahan; Sankar P Chaki; Angela M Arenas-Gamboa
Journal:  mSphere       Date:  2020-05-20       Impact factor: 4.389

9.  In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus.

Authors:  Nadège Milhau; Eyad Almouazen; Sylvie Bouteille; Imène Hellel-Bourtal; Samira Azzouz-Maache; Uruguaysito Benavides; Anne-Françoise Petavy; Thierry Marchal
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.